Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

Presentation TCT 2024

TCT 585: Impella CP and 5.5 Device Flows Are Overestimated by the SmartAssist Automated Impella Controller (AIC)

Presenter: Christian Said

October 30, 2024

Presentation TCT 2024

TCT 262: Clinical and Hemodynamic Predictors of Stabilization and Associated Complications in Cardiogenic Shock Patients Supported With Impella 5.5

Presenter: Shashank Sinha

October 29, 2024

Presentation TCT 2024

Debate Pro: Keep P8 Impella 5.5 (de-escalate VA) as Bridge to Recovery

Presenter: Amirali Masoumi

October 29, 2024

News Conference News TCT 2024

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Caitlin E. Cox

October 28, 2024

Presentation TCT 2024

TCT 582: Evaluation of LVEDP Change During High-Risk PCI With and Without Impella Support (ELVIS): A Pilot Trial

Presenter: Juergen Leick

October 28, 2024

Presentation TCT 2024

TCT 576: The Impact of Atherectomy in Severely Calcified Lesions in Patients With Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

Presenter: Batla Falah

October 28, 2024

News Conference News TCT 2024

Safety Retained When Fellows Lead Complex PCI Procedures

Yael L. Maxwell

October 27, 2024

News Daily News

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Caitlin E. Cox

October 11, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

Shelley Wood

July 02, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

Caitlin E. Cox

March 21, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

Presentation THT 2024

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Advertisement

Top Coronary Artery Disease News in 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

TCT 585: Impella CP and 5.5 Device Flows Are Overestimated by the SmartAssist Automated Impella Controller (AIC)

TCT 262: Clinical and Hemodynamic Predictors of Stabilization and Associated Complications in Cardiogenic Shock Patients Supported With Impella 5.5

Debate Pro: Keep P8 Impella 5.5 (de-escalate VA) as Bridge to Recovery

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

TCT 582: Evaluation of LVEDP Change During High-Risk PCI With and Without Impella Support (ELVIS): A Pilot Trial

TCT 576: The Impact of Atherectomy in Severely Calcified Lesions in Patients With Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

Safety Retained When Fellows Lead Complex PCI Procedures

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

TCTMD’s Top 10 Most Popular Stories for June 2024

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

TCTMD’s Top 10 Most Popular Stories for March 2024

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content